Organovo develops dynamic, multi-cellular, and fully-human tissues that closely model native architecture and biology. With the NovoGen Brioprinter® Platform, the Company designs tissues for use in applications spanning pre-clinical safety testing, disease modeling, and regenerative medicine. Tissues are commercially available through its NovoView™ Service Offering and through strategic partnerships… Read more
Promethera Biosciences is a global innovator in liver cell-based medicines whose mission is to help patients overcome acute and chronic liver diseases. Our lead clinical program, derived from our patented cell technology platform HepaStem, is designed to benefit from its immune-modulatory and anti-fibrotic properties. We are a team of international experts operating out of R&D and GMP facilities in Mont-Saint-Guibert, Belgium, and Durham, NC, USA.
High Point Clinical Trials Center has provided comprehensive (Phase I-III) clinical site services since 2008. Our 42,000 ft2 facility consists of three unique units for the execution of outpatient and inpatient clinical studies. In addition to Healthy Normal studies, HPCTC focuses on specialty populations such as Metabolic Diseases, NASH, Renal Impairment, Respiratory, CNS, Cardiovascular and Nicotine.
Clarion is a life sciences strategy and organizational consultancy that works together with global clients to envision, craft, and enable growth in dynamic markets. Across therapeutic categories, Clarion collaborates deeply with its clients to tackle their most complex cross-functional business challenges and decisions throughout the product and company lifecycle. From start-up to global multinational companies, we help assemble and deliver on inspired strategies that require creativity, insight and collaboration.
Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also developing its digital health and enterprise services. Further information is available at www.siemens-healthineers.com
Accurate. Relevant. Human. Yecuris FRG® KO animal technologies provide NASH researchers with an essential tool, capable of saving precious time during the discovery cycle. Highly customizable with exceptional physiological relevance, FRG® KO animals put the power of a humanized model directly in the hands of scientists. Since 2007, our patented animal technologies have enabled breakthrough science in liver-targeted drug development. We continue to break new ground partnering with customers seeking NASH-specific models for their studies.
CrownBio’s metabolic disease portfolio is a unique continuum of translational platforms that enable our clients to take strategic go/no-go decisions as they progress their therapeutic candidates through various stages of drug development. Our clients engage with these translational platforms, which include rodent and non-human primates, (NHP) to model human liver disease pathologies and use them to predict human efficacy and safety of therapeutic candidates.
HCD Economics is a technical economics consultancy providing analytic and strategic support to the pharmaceutical and medical device industry. Our unique relationship with the University of Chester, alongside our work with payers and decision-makers, enables us to generate meaningful evidence with academic credibility that resonates with all key stakeholders. Partnering with patient charity organizations ensures the analyses we undertake… Read more
“Jubilant Biosys has global reach and provides comprehensive drug discovery services – from target discovery to candidate selection in partnership with leading healthcare companies worldwide. With a clear scientific focus in Oncology, Metabolic Disorders, Central Nervous System (CNS) diseases, Pain and Inflammation, Jubilant Biosys has rapidly emerged as a leading collaborator for pharmaceutical and biotechnology companies worldwide… Read More
Synexus is the world’s largest site network, with 200 sites and 1,500+ employees. We provide customers with access to more than 100 million patients in key clinical development markets including the United States, Europe, Africa and Asia. Synexus has unmatched capacity to find the right patient for the right trial at the right time. Our global scale and world-class site network delivers unparalleled capability, data-driven site selection and activation, proven patient engagement and retention expertise.